Pricing Log in Create free account

Aptevo Therapeutics Inc. (APVO) vs ARAVIVE, INC (ARAV)

Aptevo Therapeutics Inc. and ARAVIVE, INC are both Biotechnology companies. Aptevo Therapeutics Inc. and ARAVIVE, INC are of similar size ($3.1M and $3.0M). ARAVIVE, INC has negative trailing earnings, so its P/E is not meaningful; Aptevo Therapeutics Inc. trades at 0.0×. Aptevo Therapeutics Inc. grew revenue faster over the last twelve months: 92.9% against −19.1%. Aptevo Therapeutics Inc. has the higher net margin (0.00% vs −569.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Aptevo Therapeutics Inc. leads on 11 and ARAVIVE, INC on 6.

Valuation

Metric APVO ARAV Biotechnology median
P/E 0.00 n/m 8.50
P/S 0.15 0.43 9.71
P/B 0.32 1.78 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.17 0.05 0.64
EV/Sales (0.34) (0.44) 9.21
Earnings yield 100,773.33% (1,500.00%) (33.15%)
Free cash flow yield (1,315.16%) (2,072.58%) (25.50%)

Profitability

Metric APVO ARAV Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (847.42%) 0.00%
Net margin 0.00% (569.65%) 0.00%
Free cash flow margin 0.00% (849.92%) 0.00%
Return on equity (446.89%) (475.98%) (56.36%)
Return on assets (186.29%) (144.19%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APVO ARAV Biotechnology median
Revenue growth (TTM) 92.94% (19.11%) 6.02%
EPS growth (last fiscal year) 99.72% (7.69%) 30.26%
Revenue growth, 5-year CAGR (26.64%) (25.57%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO ARAV Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 0.98 4.72
Net debt to EBITDA 0.83 0.77 0.96

Dividend

Metric APVO ARAV Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric APVO ARAV Biotechnology median
Market cap 3.08m 2.95m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack